The safety and efficacy of these products are not guaranteed
As of July 2025, CVS Caremark removed Zepbound from its standard national formulary
GLP-1 and GIP are incretin hormones that have been shown to influence insulin secretion, appetite, and glycemic control, while GCG primarily stimulates lipolysis, increases energy expenditure, and promotes fatty acid oxidation
What the Trials Reported About Tolerability and Safety The adverse events reported most often were gastrointestinal nausea, vomiting, diarrhea, and constipation characterized as predominantly mild to moderate, dose-dependent, and concentrated during escalation
A 15% body weight reduction the STEP-1 semaglutide benchmark is associated with type 2 diabetes remission in 37% of treated patients, 28% reduction in hypertension medication requirements, 25% improvement in sleep apnea severity, and MASH progression reversal
Palmer SC, Tendal B, Mustafa RA, Vandvik PO, Li S, Hao Q, et al